These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20817213)

  • 1. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease.
    Yasui K; Sumida Y; Mori Y; Mitsuyoshi H; Minami M; Itoh Y; Kanemasa K; Matsubara H; Okanoue T; Yoshikawa T
    Metabolism; 2011 May; 60(5):735-9. PubMed ID: 20817213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.
    Machado MV; Gonçalves S; Carepa F; Coutinho J; Costa A; Cortez-Pinto H
    Liver Int; 2012 Feb; 32(2):241-8. PubMed ID: 22098270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.
    Arase Y; Suzuki F; Kobayashi M; Suzuki Y; Kawamura Y; Matsumoto N; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Ohmoto Y; Amakawa K; Tsuji H; Hsieh SD; Kato K; Tanabe M; Ogawa K; Hara S; Kobayashi T
    Intern Med; 2011; 50(10):1081-7. PubMed ID: 21576832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; De Merulis A; Bezzi M; Osborn JF; Catalano C; Chiesa C
    Hepatology; 2014 Feb; 59(2):461-70. PubMed ID: 23843206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis.
    Targher G; Bertolini L; Rodella S; Lippi G; Zoppini G; Chonchol M
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2166-71. PubMed ID: 20724519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database.
    Terai S; Buchanan-Hughes A; Ng A; Lee IH; Hasegawa K
    J Gastroenterol; 2021 Mar; 56(3):274-284. PubMed ID: 33496858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
    Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
    JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
    Seko Y; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Mizuno N; Takemura M; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Okanoue T; Itoh Y
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study.
    Lin M; Liu C; Liu Y; Wang D; Zheng C; Shi X; Chen Z; Liu J; Li X; Yang S; Li Z
    Ann Nutr Metab; 2019; 74(4):287-295. PubMed ID: 30965331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.
    Eguchi Y; Hyogo H; Ono M; Mizuta T; Ono N; Fujimoto K; Chayama K; Saibara T;
    J Gastroenterol; 2012 May; 47(5):586-95. PubMed ID: 22328022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
    Shi HB; Fu JF; Liang L; Wang CL; Zhu JF; Zhou F; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.
    Bonora E; Targher G
    Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):372-81. PubMed ID: 22565095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.
    Targher G; Bertolini L; Rodella S; Zoppini G; Lippi G; Day C; Muggeo M
    Diabetologia; 2008 Mar; 51(3):444-50. PubMed ID: 18058083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease.
    Choe AR; Ryu DR; Kim HY; Lee HA; Lim J; Kim JS; Lee JK; Kim TH; Yoo K
    BMC Nephrol; 2020 Feb; 21(1):50. PubMed ID: 32066395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease.
    Sesti G; Fiorentino TV; Arturi F; Perticone M; Sciacqua A; Perticone F
    PLoS One; 2014; 9(2):e88569. PubMed ID: 24520400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
    Barb D; Bril F; Kalavalapalli S; Cusi K
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
    Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
    Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.